Kenta Biotech relocates to Zurich

May 29, 2012 in Medical Technology

BERN, SWITZERLAND – Kenta Biotech announced that it is relocating from Bern, Switzerland to Bio-Technopark in Zurich-Schlieren. In its new headquarters, Kenta Biotech will rent state-of-the-art laboratories, allowing it to boost research efforts and development of treatments for hospital-acquired infections.

Among the site’s advantages are its proximity to academic research centers in Zurich and the support provided by local authorities.

“This is definitely a strategic move for the company and we are now located at the best possible place for a young and innovative biotech company in Switzerland,” said Franco Merckling, CEO of Kenta Biotech.

Kenta Biotech has for six years developed technologies and products to fight hospital-acquired infections. With its relocation, officials say the company hopes to send a positive message to current and future investors and partners.

Be the first to like.
VN:F [1.9.22_1171]
Rating: 0.0/5 (0 votes cast)

Article source:

Be Sociable, Share!
Bookmark and Share

Leave a reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>